ACTIVE SUBSTANCE / INN

MARIBAVIR

Brand name(s): Livtencity, LIVTENCITY
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA215596
Cytomegalovirus Infections
ACTIVE SUBSTANCE
Maribavir
REGULATORS
FDA · EMA
SPONSORS / MAH
Takeda Pharmaceuticals International AG Ireland Branch, TAKEDA PHARMS USA
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LIVTENCITYNDA215596TAKEDA PHARMS USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LivtencityTakeda Pharmaceuticals International AG Ireland BranchAuthorised09/11/2022Cytomegalovirus Infections

FULL INTELLIGENCE ON MARIBAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →